

Scientific, Regulatory & Strategic Consulting Services For The Life Science Industry
Our Services



Business Asset Evaluation
Scientific evaluation of business assets for in-licensing activities, evaluation and analysis of data sets, due diligence and business intelligence builds. Services include market analysis and pitch deck generation
Drug Discovery/Preclinical Development
Evaluation and recommendation of in vitro and in vivo animal models, pharmacology, toxicology, PK/PD studies, study design and protocol builds, target identification and report summaries. Services include poster and presentation synthesis
Medical Writing/Regulatory Strategy
Report builds, IND and IB synthesis, NDA/BLA builds, preIND summaries, regulatory responses, FDA, EMA, PDMA. Strategy for biologics, small molecule, cellular therapeutics. 505b1, 505b2, 505j

Clients we serve
Biotechs/Start-Ups
Consulting Firms
Pharmaceutical Companies
Laboratories
Institutions/Universities
Students/Professors